Lynch & Associates Abbott Laboratories Transaction History

Lynch & Associates

$467 Million
Q3 2024

A detailed history of Lynch & Associates transactions in Abbott Laboratories stock. As of the latest transaction made, Lynch & Associates holds 56,856 shares of ABT stock, worth $6.67 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares

56,856

Previous 57,105 0.44%

Holding current value

$6.67 Million

Previous $5.93 Million 9.25%

% of portfolio

1.39%

Previous 1.35%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$100.07 - $118.13 $24,917 - $29,414	-249 Reduced 0.44%	56,856 $6.48 Million
Q2 2024 Aug 06, 2024	BUY	$100.73 - $112.44 $140,417 - $156,741	1,394 Added 2.5%	57,105 $5.93 Million
Q1 2024 Apr 09, 2024	SELL	$109.52 - $120.96 $297,127 - $328,164	-2,713 Reduced 4.64%	55,711 $6.33 Million
Q4 2023 Jan 08, 2024	SELL	$90.19 - $110.4 $182,724 - $223,670	-2,026 Reduced 3.35%	58,424 $6.43 Million
Q3 2023 Oct 24, 2023	SELL	$95.53 - $114.62 $56,171 - $67,396	-588 Reduced 0.96%	60,450 $5.85 Million
Q2 2023 Oct 24, 2023	SELL	$100.78 - $112.29 $108,237 - $120,599	-1,074 Reduced 1.73%	61,038 $6.65 Million
Q2 2023 Jul 13, 2023	SELL	$100.78 - $112.29 $108,237 - $120,599	-1,074 Reduced 1.73%	61,038 $6.65 Million
Q1 2023 Oct 24, 2023	BUY	$96.86 - $114.01 $104,027 - $122,446	1,074 Added 1.76%	62,112 $6.29 Million
Q1 2023 Apr 04, 2023	SELL	$96.86 - $114.01 $103,833 - $122,218	-1,072 Reduced 1.7%	62,112 $6.29 Million
Q4 2022 Oct 24, 2023	BUY	$95.06 - $111.52 $259,894 - $304,895	2,734 Added 4.52%	63,184 $6.94 Million
Q4 2022 Jan 05, 2023	SELL	$95.06 - $111.52 $48,575 - $56,986	-511 Reduced 0.8%	63,184 $6.94 Million
Q3 2022 Oct 03, 2022	SELL	$96.76 - $112.03 $141,850 - $164,235	-1,466 Reduced 2.25%	63,695 $6.16 Million
Q2 2022 Jul 06, 2022	SELL	$102.07 - $123.37 $39,705 - $47,990	-389 Reduced 0.59%	65,161 $7.08 Million
Q1 2022 Apr 08, 2022	SELL	$114.02 - $139.04 $141,954 - $173,104	-1,245 Reduced 1.86%	65,550 $7.76 Million
Q4 2021 Jan 11, 2022	SELL	$115.53 - $141.46 $27,149 - $33,243	-235 Reduced 0.35%	66,795 $9.4 Million
Q3 2021 Oct 12, 2021	SELL	$116.66 - $129.06 $58,446 - $64,659	-501 Reduced 0.74%	67,030 $7.92 Million
Q2 2021 Jul 21, 2021	SELL	$105.79 - $124.53 $28,351 - $33,374	-268 Reduced 0.4%	67,531 $7.83 Million
Q1 2021 Apr 09, 2021	BUY	$108.84 - $128.23 $31,563 - $37,186	290 Added 0.43%	67,799 $8.13 Million
Q4 2020 Jan 20, 2021	SELL	$105.0 - $114.42 $57,225 - $62,358	-545 Reduced 0.8%	67,509 $7.39 Million
Q3 2020 Oct 21, 2020	BUY	$91.64 - $111.29 $2,291 - $2,782	25 Added 0.04%	68,054 $7.41 Million
Q2 2020 Jul 20, 2020	SELL	$76.57 - $98.0 $57,810 - $73,990	-755 Reduced 1.1%	68,029 $6.22 Million
Q1 2020 Apr 28, 2020	SELL	$62.82 - $91.86 $106,794 - $156,162	-1,700 Reduced 2.41%	68,784 $5.43 Million
Q4 2019 Jan 10, 2020	SELL	$78.51 - $87.4 $62,022 - $69,046	-790 Reduced 1.11%	70,484 $6.12 Million
Q3 2019 Oct 03, 2019	SELL	$81.84 - $88.74 $22,342 - $24,226	-273 Reduced 0.38%	71,274 $5.96 Million
Q2 2019 Jul 19, 2019	SELL	$72.88 - $85.0 $50,432 - $58,820	-692 Reduced 0.96%	71,547 $6.02 Million
Q1 2019 Apr 25, 2019	BUY	$66.22 - $80.06 $4,502 - $5,444	68 Added 0.09%	72,239 $5.78 Million
Q4 2018 Jan 10, 2019	BUY	$65.56 - $74.27 $1.1 Million - $1.24 Million	16,722 Added 30.16%	72,171 $5.22 Million
Q2 2018 Jul 09, 2018	BUY	$57.57 - $63.54 $147,954 - $163,297	2,570 Added 4.86%	55,449 $3.38 Million
Q1 2018 Apr 06, 2018	SELL	$56.27 - $63.62 $56,270 - $63,620	-1,000 Reduced 1.86%	52,879 $3.17 Million
Q4 2017 Jan 04, 2018	SELL	$53.68 - $57.47 $29,148 - $31,206	-543 Reduced 1.0%	53,879 $3.08 Million
Q3 2017 Oct 18, 2017	BUY	$48.06 - $53.64 $2.62 Million - $2.92 Million	54,422	54,422 $2.9 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lynch & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Lynch & Associates with notifications on news.

Account

Lynch & Associates Abbott Laboratories Transaction History